Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study.
- DOI
- 10.1016/s2665-9913(24)00298-4
- Published
- 2025 Apr
- Container
- The Lancet. Rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2665-9913-24-00298-4,
title = {Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study.},
author = {Farge D and Biard L and Weil B and Girault V and Lansiaux P and Munia I and Loisel S and Charles C and Saout J and Resche-Rigon M and Korganow AS and Beuvon C and Pugnet G and Cacciatore C and Abisror N and Taupin JL and Cras A and Lowdell MW and Tarte K},
year = {2025},
journal = {The Lancet. Rheumatology},
doi = {10.1016/s2665-9913(24)00298-4},
url = {https://doi.org/10.1016/s2665-9913(24)00298-4}
}RIS
TY - JOUR TI - Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study. AU - Farge D AU - Biard L AU - Weil B AU - Girault V AU - Lansiaux P AU - Munia I AU - Loisel S AU - Charles C AU - Saout J AU - Resche-Rigon M AU - Korganow AS AU - Beuvon C AU - Pugnet G AU - Cacciatore C AU - Abisror N AU - Taupin JL AU - Cras A AU - Lowdell MW AU - Tarte K PY - 2025 JO - The Lancet. Rheumatology DO - 10.1016/s2665-9913(24)00298-4 UR - https://doi.org/10.1016/s2665-9913(24)00298-4 ER -
APA
D, F., L, B., B, W., V, G., P, L., I, M., S, L., C, C., J, S., M, R., AS, K., C, B., G, P., C, C., N, A., JL, T., A, C., MW, L., & K, T. (2025). Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(24)00298-4
Source records
- pubmed · retrieved 2026-09-26T22:14:07.820Z